721-13-1 Usage
Uses
Used in Pharmaceutical Industry:
3-[2,2-DIFLUOROBENZO[1,3]-DIOXOL-5-YL]ACRYLIC ACID is used as a key intermediate in the synthesis of pyrazolyl phenyl urea derivatives, which are known to act as inhibitors of p38 kinase and/or tumor necrosis factor (TNF). These inhibitors play a crucial role in the development of anti-inflammatory and immunomodulatory drugs.
Used in Anticancer Applications:
3-[2,2-DIFLUOROBENZO[1,3]-DIOXOL-5-YL]ACRYLIC ACID is used as an anti-cancer agent, where it can be incorporated into the design and synthesis of novel anticancer drugs. Its unique structure and properties may contribute to the development of targeted therapies for various types of cancer.
Used in Antiviral Applications:
3-[2,2-DIFLUOROBENZO[1,3]-DIOXOL-5-YL]ACRYLIC ACID is also used as a hepatitis C virus inhibitor. Its incorporation into antiviral drug development can potentially lead to the creation of effective treatments for hepatitis C, a viral infection that affects the liver and can cause severe health complications if left untreated.
Check Digit Verification of cas no
The CAS Registry Mumber 721-13-1 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 7,2 and 1 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 721-13:
(5*7)+(4*2)+(3*1)+(2*1)+(1*3)=51
51 % 10 = 1
So 721-13-1 is a valid CAS Registry Number.
721-13-1Relevant academic research and scientific papers
Novel ether derivatives
-
Page/Page column 10, (2010/02/14)
The present invention provides the compounds of formula (I) their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, compositions containing them and their man
NOVEL OXAZOLE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS
-
Page 21, (2010/02/08)
Object of the present invention are compounds of the general formla (1), their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and thei
